SCHEMBL7781364

SCHEMBL7781364

[CH]1CCCOCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL420031 0.93
SCHEMBL6892227 0.90 ALDH1A1 (0.50)
SCHEMBL20680540 0.86 ALDH1A1 (0.53)
SCHEMBL15561417 0.86 ALDH1A1 (0.53)
Water SCHEMBL5996203 0.83 ALDH1A1 (0.50)
SCHEMBL420034 0.83
SCHEMBL15741540 0.81
SCHEMBL15741587 0.81
SCHEMBL20142385 0.79
SCHEMBL4358750 0.78 ALDH1A1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399297-A1 Novel Glutamine Analogs JACOBIO PHARMACEUTICALS CO., LTD (CN) 2023-12-14 US claimed
WO-2023250029-A1 BIFUNCTIONAL COMPOUNDS CONTAINING SUBSTITUTED PYRIMIDINE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEASOME PATHWAY NIKANG THERAPEUTICS, INC. (US) 2023-12-28 WO disclosed
US-20230399297-A1 Novel Glutamine Analogs JACOBIO PHARMACEUTICALS CO., LTD (CN) 2023-12-14 US disclosed
EP-0606096-B1 OO-t-alkyl O-polycaprolactone monoperoxycarbonates ATOFINA CHEM INC (US) 2001-09-12 EP disclosed
EP-0606096-A1 OO-t-alkyl O-polycaprolactone monoperoxycarbonates ELF ATOCHEM NORTH AMERICA, INC. (US) 1994-07-13 EP disclosed
US-5314970-A Block and graft copolymers; compatibilizing agents ELF ATOCHEM NORTH AMERICA, INC. (US) 1994-05-24 US disclosed
EP-0593936-A1 N-[2-hydroxy-3-(2H-benzotriazol-2-yl)benzyl]oxamides as light stabilisers ELF ATOCHEM NORTH AMERICA, INC. (US) 1994-04-27 EP disclosed